Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Neonatal antibiotic treat… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Kontaktformulär








 


OBS! Vill du ha svar, ange e-post eller telefonnummer!




Neonatal antibiotic treatment is a risk factor for early wheezing.

Artikel i vetenskaplig tidskrift
Författare Bernt Alm
Laslo Erdes
Per Möllborg
Rolf Pettersson
Gunnar Norvenius
Nils Åberg
Göran Wennergren
Publicerad i Pediatrics
Volym 121
Nummer/häfte 4
Sidor 697-702
ISSN 1098-4275
Publiceringsår 2008
Publicerad vid Institutionen för kliniska vetenskaper, Avdelningen för pediatrik
Sidor 697-702
Språk en
Länkar dx.doi.org/10.1542/peds.2007-1232
Ämnesord Administration, Inhalation, Adrenal Cortex Hormones, therapeutic use, Age Factors, Age of Onset, Analysis of Variance, Anti-Bacterial Agents, adverse effects, therapeutic use, Asthma, chemically induced, drug therapy, epidemiology, Bronchopulmonary Dysplasia, diagnosis, drug therapy, Cohort Studies, Confidence Intervals, Female, Follow-Up Studies, Humans, Incidence, Infant, Infant, Newborn, Male, Odds Ratio, Probability, Questionnaires, Respiratory Sounds, physiopathology, Retrospective Studies, Risk Factors, Severity of Illness Index, Sweden, epidemiology
Ämneskategorier Pediatrik

Sammanfattning

OBJECTIVE: The use of antibiotics in infancy and subsequent changes in the intestinal bacterial flora have been discussed as risk factors for the development of asthma. However, it has been difficult to exclude the possibility that antibiotics have been given in early episodes of wheezing. As a result, there has been a risk of reverse causation. To minimize the risk of reverse causation, we have focused on the effect of antibiotics that are already administered on the neonatal ward. METHODS: In a cohort study of infants born in western Sweden in 2003, we studied the development of wheezing. The families of the infants were randomly selected and sent a questionnaire at child ages 6 and 12 months. The response rate was 68.5% to the 6-month questionnaire and 68.9% to the 12-month questionnaire. RESULTS: At 12 months, 20.2% of infants had had 1 or more episodes of wheezing, and 5.3% had had 3 or more episodes. Inhaled corticosteroids had been taken by 4.1% of the infants. Independent risk factors for wheezing disorder treated with inhaled corticosteroids were neonatal antibiotic treatment, male gender, gestational age of <37 weeks, having a mother with asthma, having a sibling with asthma or eczema, and breastfeeding for <5 months. CONCLUSIONS: Treatment with antibiotics in the neonatal period was an independent risk factor for wheezing that was treated with inhaled corticosteroids at 12 months of age. These results indirectly support the hypothesis that an alteration in the intestinal flora can increase the risk of subsequent wheezing.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?